Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and chemotherapy in locally advanced breast cancer
NCT00365417Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab in breast cancer, sponsored by NSABP Foundation. Started Aug 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00365417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365417.